|
|
文献清单:2024编辑精选文章(二)| MDPI Vaccines |
|
期刊名:Vaccines
期刊主页:https://www.mdpi.com/journal/vaccines?n1=9&_utm_from=3a1f553a47
在全球公共卫生领域,疫苗接种仍然是预防传染病的重要手段。2024年编辑精选文章聚焦于疫苗的最新进展与研究,特别是针对新兴传染病的应对措施。通过深入探讨疫苗的安全性、有效性及其在不同人群中的应用,我们希望激发更广泛的讨论与合作,以应对未来的健康挑战。
1.
英文标题Recent Scientific Advancements towards a Vaccine against Group A Streptococcus
中文标题: A群链球菌疫苗研发新进展
文章链接:https://www.mdpi.com/2076-393X/12/3/272
MDPI引用格式
Fan, J.; Toth, I.; Stephenson, R.J. Recent Scientific Advancements towards a Vaccine against Group A Streptococcus. Vaccines 2024, 12, 272. https://doi.org/10.3390/vaccines12030272
2.
英文标题Microfluidic Synthesis of Scalable Layer-by-Layer Multiple Antigen Nano-Delivery Platform for SARS-CoV-2 Vaccines
中文标题: 用于SARS-CoV-2疫苗的可规模化逐层组装多抗原纳米递送平台的微流控制备
文章链接:https://www.mdpi.com/2076-393X/12/3/339
MDPI引用格式
Xu, Y.; Masuda, K.; Groso, C.; Hassan, R.; Zhou, Z.; Broderick, K.; Tsuji, M.; Tison, C. Microfluidic Synthesis of Scalable Layer-by-Layer Multiple Antigen Nano-Delivery Platform for SARS-CoV-2 Vaccines. Vaccines 2024, 12, 339. https://doi.org/10.3390/vaccines12030339
3.
英文标题Development and Evaluation of an Immunoinformatics-Based Multi-Peptide Vaccine against Acinetobacter baumannii Infection
中文标题: 基于免疫信息学的鲍曼不动杆菌感染多肽疫苗开发与评价
文章链接:https://www.mdpi.com/2076-393X/12/4/358
MDPI引用格式
Jeffreys, S.; Tompkins, M.P.; Aki, J.; Papp, S.B.; Chambers, J.P.; Guentzel, M.N.; Hung, C.-Y.; Yu, J.-J.; Arulanandam, B.P. Development and Evaluation of an Immunoinformatics-Based Multi-Peptide Vaccine against Acinetobacter baumannii Infection. Vaccines 2024, 12, 358. https://doi.org/10.3390/vaccines12040358
4.
英文标题Effectiveness of Nirsevimab Immunoprophylaxis Administered at Birth to Prevent Infant Hospitalisation for Respiratory Syncytial Virus Infection: A Population-Based Cohort Study
中文标题: 出生时接种尼塞韦单抗预防婴儿呼吸道合胞病毒感染住院的有效性:一项基于人群的队列研究
文章链接:https://www.mdpi.com/2076-393X/12/4/383
MDPI引用格式
Ezpeleta, G.; Navascués, A.; Viguria, N.; Herranz-Aguirre, M.; Juan Belloc, S.E.; Gimeno Ballester, J.; Muruzábal, J.C.; García-Cenoz, M.; Trobajo-Sanmartín, C.; Echeverria, A.; et al. Effectiveness of Nirsevimab Immunoprophylaxis Administered at Birth to Prevent Infant Hospitalisation for Respiratory Syncytial Virus Infection: A Population-Based Cohort Study. Vaccines 2024, 12, 383. https://doi.org/10.3390/vaccines12040383
5.
英文标题Design and Characterization of a New Formulation for the Delivery of COVID-19-mRNA Vaccine to the Nasal Mucosa
中文标题: COVID-19 mRNA疫苗鼻黏膜递送新制剂的设计与表征
文章链接:https://www.mdpi.com/2076-393X/12/4/409
MDPI引用格式
Altay Benetti, A.; Tan, E.Y.Z.; Chang, Z.W.; Bae, K.H.; Thwin, M.T.; Muthuramalingam, R.P.K.; Liao, K.-C.; Wan, Y.; Ng, L.F.P.; Renia, L.; et al. Design and Characterization of a New Formulation for the Delivery of COVID-19-mRNA Vaccine to the Nasal Mucosa. Vaccines 2024, 12, 409. https://doi.org/10.3390/vaccines12040409
6.
英文标题Impact of HPV Vaccination on the Incidence of High-Grade Cervical Intraepithelial Neoplasia (CIN2+) in Women Aged 20–25 in the Northern Part of Norway: A 15-Year Study
中文标题: 挪威北部地区20-25岁女性HPV疫苗接种对高级别宫颈上皮内瘤变(CIN2+)发病率的影响:一项15年研究
文章链接:https://www.mdpi.com/2076-393X/12/4/421
MDPI引用格式
Mikalsen, M.P.; Simonsen, G.S.; Sørbye, S.W. Impact of HPV Vaccination on the Incidence of High-Grade Cervical Intraepithelial Neoplasia (CIN2+) in Women Aged 20–25 in the Northern Part of Norway: A 15-Year Study. Vaccines 2024, 12, 421. https://doi.org/10.3390/vaccines12040421
7.
英文标题Therapeutic Vaccines for HPV-Associated Cervical Malignancies: A Systematic Review
中文标题: HPV相关宫颈恶性肿瘤治疗性疫苗:系统综述
文章链接:https://www.mdpi.com/2076-393X/12/4/428
MDPI引用格式
Alouini, S.; Pichon, C. Therapeutic Vaccines for HPV-Associated Cervical Malignancies: A Systematic Review. Vaccines 2024, 12, 428. https://doi.org/10.3390/vaccines12040428
8.
英文标题mRNA Vaccine for Alzheimer’s Disease: Pilot Study
中文标题: 阿尔茨海默病mRNA疫苗:初步研究
文章链接:https://www.mdpi.com/2076-393X/12/6/659
MDPI引用格式
Hovakimyan, A.; Chilingaryan, G.; King, O.; Capocchi, J.K.; Chadarevian, J.P.; Davtyan, H.; Kniazev, R.; Agadjanyan, M.G.; Ghochikyan, A. mRNA Vaccine for Alzheimer’s Disease: Pilot Study. Vaccines 2024, 12, 659. https://doi.org/10.3390/vaccines12060659
9.
英文标题An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity
中文标题: 先天性免疫缺陷患者SARS-CoV-2特异性免疫增强策略综述
文章链接:https://www.mdpi.com/2076-393X/12/6/675
MDPI引用格式
Chang-Rabley, E.; van Zelm, M.C.; Ricotta, E.E.; Edwards, E.S.J. An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity. Vaccines 2024, 12, 675. https://doi.org/10.3390/vaccines12060675
10.
英文标题Exploring the Potential of Natural Killer Cell-Based Immunotherapy in Targeting High-Grade Serous Ovarian Carcinomas
中文标题: 基于自然杀伤细胞的免疫疗法靶向治疗高级别浆液性卵巢癌的潜力探索
文章链接:https://www.mdpi.com/2076-393X/12/6/677
MDPI引用格式
Kaur, K.; Sanghu, J.; Memarzadeh, S.; Jewett, A. Exploring the Potential of Natural Killer Cell-Based Immunotherapy in Targeting High-Grade Serous Ovarian Carcinomas. Vaccines 2024, 12, 677. https://doi.org/10.3390/vaccines12060677
11.
英文标题SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma
中文标题: 多发性硬化患者对mRNA/病毒载体/蛋白疫苗的SARS-CoV-2特异性免疫细胞因子谱:超越γ干扰素的分析
文章链接:https://www.mdpi.com/2076-393X/12/6/684
MDPI引用格式
Al Rahbani, G.K.; Woopen, C.; Dunsche, M.; Proschmann, U.; Ziemssen, T.; Akgün, K. SARS-CoV-2-Specific Immune Cytokine Profiles to mRNA, Viral Vector and Protein-Based Vaccines in Patients with Multiple Sclerosis: Beyond Interferon Gamma. Vaccines 2024, 12, 684. https://doi.org/10.3390/vaccines12060684
12.
英文标题Progress and Challenges in Measles and Rubella Elimination in the WHO European Region
中文标题: 世界卫生组织欧洲区域消除麻疹与风疹的进展与挑战
文章链接:https://www.mdpi.com/2076-393X/12/6/696
MDPI引用格式
Muscat, M.; Ben Mamou, M.; Reynen-de Kat, C.; Jankovic, D.; Hagan, J.; Singh, S.; Datta, S.S. Progress and Challenges in Measles and Rubella Elimination in the WHO European Region. Vaccines 2024, 12, 696. https://doi.org/10.3390/vaccines12060696
特别声明:本文转载仅仅是出于传播信息的需要,并不意味着代表本网站观点或证实其内容的真实性;如其他媒体、网站或个人从本网站转载使用,须保留本网站注明的“来源”,并自负版权等法律责任;作者如果不希望被转载或者联系转载稿费等事宜,请与我们接洽。